NCT00000496View on ClinicalTrials.gov

Platelet Drug Trial in Coronary Disease Progression

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 1979

Study Completion Date

December 31, 1982

Conditions

Cardiovascular DiseasesCoronary DiseaseHeart DiseasesMyocardial Ischemia

Interventions

DRUG

aspirin

DRUG

dipyridamole

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000496 - Platelet Drug Trial in Coronary Disease Progression | Biotech Hunter | Biotech Hunter